Biotech

All Articles

A better examine Fierce Biotech's Tough 15

.Within this full week's incident of "The Best Pipe," our team're diving into Ferocious Biotech's ye...

Lilly faces phase 2 failing of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's celebration commemorating the commend...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial leadership hirings, firings as we...

Lykos are going to inquire FDA to reevaluate its own choice adhering to rejection of MDMA treatment for post-traumatic stress disorder

.Observing an unsatisfactory presenting for Lykos Rehabs' MDMA prospect for post-traumatic stress di...

AN 2 fifty percents headcount, stops phase 3 trial after information disappoint

.AN2 Therapies is actually re-thinking its company in response to uninspired midphase data, swearing...

Merck pays for $700M for bispecific, snooping autoimmune opening and also odds to challenge Amgen in cancer cells

.Merck &amp Co. is actually spending $700 million beforehand to challenge Amgen in a blood stream ca...

Gilead pays out J&ampJ $320M to exit licensing package for seladelpar

.With Gilead Sciences almost an FDA decision for its own liver illness drug seladelpar, the business...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks may observe the providers establishing tents at basecamp behind Eli Lilly in an att...

Entero giving up team, leaving office as well as stopping briefly R&ampD

.Cushion Liquidators has transformed Entero Therapeutics white colored as a slab. The lender ordered...

Exelixis loses ADC after deciding it's no suit for Tivdak

.Exelixis is actually quiting on its own cells aspect (TF)- targeting antibody-drug conjugate after ...